Revenue from top 20 women health products in the U.S. 2016

Top 20 health products for women in the U.S. based on revenue in 2016 (in million U.S. dollars)

Revenue from top 20 women health products in the U.S. 2016 This statistic displays the top 20 products for women's health based on revenue in the United States generated during 2016. In that year, NuvaRing from Merck generated some 576 million U.S. dollars in revenues. Contraceptives have become much more affordable in the United States as there are no longer patents that prevent a combined use of estrogen and progesterone for oral contraception. Both of these hormones are easy to synthesize and manufacture.
Show more

Top 20 health products for women in the U.S. based on revenue in 2016 (in million U.S. dollars)

Loading statistic...
Expand statistic
Product name (company)Revenue in million U.S. dollars
Prolia (Amgen)1,049
Premarin (Pfizer)956
Mirena (Bayer)776
Forteo (Eli Lilly)771
NuvaRing (Merck)576
Nexplanon (Merck)420
Lo Loestrin Fe (Allergan)404
Estrace Cream (Allergan)379
Makena (AMAG Pharm.)334
Minastrin 24 FE (Allergan)326
Vagifem (Novo Nordisk)302
Lupron (AbbVie)285
Gonal-F (Merck KGaA)221
Follistim (Merck)157
Yasmin (Bayer)142
Oral contrception franchise (J&J/Pfizer)129
Natazia (Bayer)104
Minivelle (Hisamitsu)88
Caltrate (Pfizer)87
Junel/Loestrin (Teva)79
Product name (company)Revenue in million U.S. dollars
Prolia (Amgen)1,049
Premarin (Pfizer)956
Mirena (Bayer)776
Forteo (Eli Lilly)771
NuvaRing (Merck)576
Nexplanon (Merck)420
Lo Loestrin Fe (Allergan)404
Estrace Cream (Allergan)379
Makena (AMAG Pharm.)334
Minastrin 24 FE (Allergan)326
Vagifem (Novo Nordisk)302
Lupron (AbbVie)285
Gonal-F (Merck KGaA)221
Follistim (Merck)157
Yasmin (Bayer)142
Oral contrception franchise (J&J/Pfizer)129
Natazia (Bayer)104
Minivelle (Hisamitsu)88
Caltrate (Pfizer)87
Junel/Loestrin (Teva)79
Download Settings Share
Download started
Please be patient - this may take a moment
This statistic displays the top 20 products for women's health based on revenue in the United States generated during 2016. In that year, NuvaRing from Merck generated some 576 million U.S. dollars in revenues. Contraceptives have become much more affordable in the United States as there are no longer patents that prevent a combined use of estrogen and progesterone for oral contraception. Both of these hormones are easy to synthesize and manufacture.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Women's health in the U.S.
Women's health in the U.S.

All Information
in one Presentation

Women's health in the U.S.

Everything On "Women's health in the U.S." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Contraception in the U.S."
  • Overview
  • U.S. market
  • Use
  • Adolescent use
  • Miscellaneous
The most important statistics
  • Extra: Developing regions
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.